Show simple item record

dc.contributor.authorDregan, Alex
dc.contributor.authorMcNeill, Ann
dc.contributor.authorGaughran, Fiona
dc.contributor.authorJones, Peter B.
dc.contributor.authorBazley, Anna
dc.contributor.authorCross, Sean
dc.contributor.authorLillywhite, Kate
dc.contributor.authorArmstrong, David
dc.contributor.authorSmith, Shubulade
dc.contributor.authorOsborn, David P. J.
dc.contributor.authorStewart, Robert
dc.contributor.authorWykes, Til
dc.contributor.authorHotopf, Matthew
dc.description.abstractBackground: To estimate the potential gain in life expectancy from addressing modifiable risk factors for all-cause mortality (excluding suicide and deaths from accidents or violence) across specific serious mental illness (SMI) subgroups, namely schizophrenia, schizoaffective disorders, and bipolar disorders in a Western population. Methods: We have used relative risks from recent meta-analyses to estimate the population attribution fraction (PAF) due to specific modifiable risk factors known to be associated with all-cause mortality within SMI. The potential gain in life expectancy at birth, age 50 and age 65 years were assessed by estimating the combined effect of modifiable risk factors from different contextual levels (behavioural, healthcare, social) and accounting for the effectiveness of existing interventions tackling these factors. Projections for annual gain in life expectancy at birth during a two-decade was estimated using the Annual Percentage Change (APC) formula. The predicted estimates were based on mortality rates for year 2014–2015. Results: Based on the effectiveness of existing interventions targeting these modifiable risk factors, we estimated potential gain in life expectancy at birth of four (bipolar disorders), six (schizoaffective disorders), or seven years (schizophrenia). The gain in life expectancy at age 50 years was three (bipolar disorders) or five (schizophrenia and schizoaffective disorders) years. The projected gain in life expectancy at age 65 years was three (bipolar disorders) or four (schizophrenia and schizoaffective disorders) years. Conclusions: The implementation of existing interventions targeting modifiable risk factors could narrow the current mortality gap between the general and the SMI populations by 24% (men) to 28% (women). These projections represent ideal circumstances and without the limitation of overestimation which often comes with PAFs.
dc.publisherPublic Library of Science
dc.rightsAttribution 4.0 International (CC BY 4.0)en
dc.subjectResearch Article
dc.subjectBiology and life sciences
dc.subjectMedicine and health sciences
dc.subjectResearch and analysis methods
dc.subjectPhysical sciences
dc.titlePotential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom
prism.publicationNamePLOS ONE
datacite.contributor.supervisoreditor: Guloksuz, Sinan
dc.contributor.orcidDregan, Alex [0000-0002-7620-4902]
dc.contributor.orcidJones, Peter B. [0000-0002-0387-880X]

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International (CC BY 4.0)
Except where otherwise noted, this item's licence is described as Attribution 4.0 International (CC BY 4.0)